Clinical Trials Directory

Trials / Completed

CompletedNCT00893815

Prevalence and Predictors of Neurocognitive Impairment Among HIV-infected Patients

Status
Completed
Phase
Study type
Observational
Enrollment
250 (actual)
Sponsor
Henry M. Jackson Foundation for the Advancement of Military Medicine · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

Despite the advent of highly active antiretroviral therapy (HAART), the prevalence of neurocognitive impairment among HIV-infected patients continues to be an important issue. Although severe forms of AIDS-related dementia have diminished, milder forms of cognitive impairment have been noted among approximately 30% of asymptomatic HIV patients. Studies among HIV-infected U.S. military personnel regarding neurocognitive function have largely been limited to the early 1990s, before the advent of HAART. In these studies subtle neurobehavioral changes were noted among asymptomatic HIV-positive military personnel. This study proposes to determine the prevalence of neurocognitive deficits among HIV-positive military beneficiaries during the era of HAART who are participants of the U.S. Military HIV Natural History Study. The prevalence ascertained in this study will be compared to HIV-negative military beneficiaries who are demographically similar to the HIV positive group. The sample size of the study is to have complete testing on 200 HIV positive and 50 HIV-negative participants; due to the possibility of attrition before study completion, the investigators will enroll up to 300 participants (240 HIV-positive and 60 HIV-negative) to achieve this sample size. The investigators' rates among HIV-positive patients found in this study will also be contextualized in the setting of the prevalence of prior neurocognitive deficits seen in a HIV positive U.S. military population studied in the 1990s, contemporary rates among civilian HIV-infected persons, and normative values in the general HIV-negative population. Compared to other data in the field of neuropsychology, this study is novel in that the HIV population studied is composed largely of HIV patients who have been diagnosed early in their HIV infection; have open, free access to antiretrovirals to begin therapy earlier than most other cohorts; and consists of highly-functioning, educated individuals.

Detailed description

Abbreviations: DOD - U.S. Department of Defense; CD4 - cluster of differentiation 4

Conditions

Timeline

Start date
2009-04-01
Primary completion
2011-06-01
Completion
2011-09-01
First posted
2009-05-06
Last updated
2025-08-28
Results posted
2025-08-28

Locations

3 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00893815. Inclusion in this directory is not an endorsement.